Middle East & Africa Upstream Bioprocessing Market Forecast to 2030

At 12.6% CAGR, Middle East & Africa Upstream Bioprocessing Market is Speculated to be Worth US$ 712.66 Million by 2030, says the Research Team.

According to the Research Team’ research, the Middle East & Africa upstream bioprocessing market was valued at US$ 275.22 million in 2022 and is expected to reach US$ 712.66 million by 2030, registering a CAGR of 12.6% from 2022 to 2030. Commercial use of single-use bioreactors and Technological advancements are among the critical factors attributed to the Middle East & Africa upstream bioprocessing market expansion.

Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market.

On the contrary, stringent regulatory framework hampers the growth of Middle East & Africa upstream bioprocessing market.

Based on product type, the Middle East & Africa upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters segment held 35.6% market share in 2022, amassing US$ 97.87 million. It is projected to garner US$ 248.67 million by 2030 to expand at 12.4% CAGR during 2022-2030.

Based on workflow, the Middle East & Africa upstream bioprocessing market is segmented into media preparation, cell culture, and cell separation. The cell separation segment held 44.4% share of Middle East & Africa upstream bioprocessing market in 2022, amassing US$ 122.16 million. It is projected to garner US$ 325.53 million by 2030 to expand at 13.0% CAGR during 2022-2030.

By usage type, the Middle East & Africa upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use segment held 55.5% share of Middle East & Africa upstream bioprocessing market in 2022, amassing US$ 152.64 million. It is projected to garner US$ 402.12 million by 2030 to expand at 12.9% CAGR during 2022-2030.

In terms of mode, the Middle East & Africa upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house segment held 63.9% share of Middle East & Africa upstream bioprocessing market in 2022, amassing US$ 175.84 million. It is projected to garner US$ 447.49 million by 2030 to expand at 12.4% CAGR during 2022-2030.

Based on country, the Middle East & Africa upstream bioprocessing market has been categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 34.6% share of Middle East & Africa upstream bioprocessing market in 2022. It was assessed at US$ 95.12 million in 2022 and is likely to hit US$ 249.61 million by 2030, exhibiting a CAGR of 12.8% during 2022-2030.

Key players operating in the Middle East & Africa upstream bioprocessing market are Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, and Corning Inc, among others.

In January 2023, Sartorius collaborated with RoosterBio Inc to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) – based exosome production platform that delivers industry-leading yield, purity, and potency.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa upstream bioprocessing market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa upstream bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Upstream Bioprocessing Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Middle East & Africa Upstream Bioprocessing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Commercial Use of Single-Use Bioreactors
5.1.2 Outsourcing of Biopharmaceutical Manufacturing
5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
5.2 Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Market Opportunities
5.3.1 Technological Advancements
5.4 Future Trends
5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
5.5 Impact of Drivers and Restraints:
6. Upstream Bioprocessing Market – Middle East & Africa Analysis
7. Middle East & Africa Upstream Bioprocessing Market Analysis – by Product Type
7.1 Bioreactors/Fermenters
7.1.1 Overview
7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Cell Culture
7.2.1 Overview
7.2.2 Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Filters
7.3.1 Overview
7.3.2 Filters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Bags and Containers
7.4.1 Overview
7.4.2 Bags and Containers: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Upstream Bioprocessing Market Analysis – by Workflow
8.1 Media Preparation
8.1.1 Overview
8.1.2 Media Preparation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Cell Culture
8.2.1 Overview
8.2.2 Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Cell Separation
8.3.1 Overview
8.3.2 Cell Separation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Upstream Bioprocessing Market Analysis – by Usage Type
9.1 Single-use
9.1.1 Overview
9.1.2 Single-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Multi-use
9.2.1 Overview
9.2.2 Multi-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Upstream Bioprocessing Market Analysis – by Mode
10.1 In-house
10.1.1 Overview
10.1.2 In-house: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Outsourced
10.2.1 Overview
10.2.2 Outsourced: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Upstream Bioprocessing Market – Country Analysis
11.1 Middle East & Africa Market Overview
11.1.1 Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast Analysis – by Country
11.1.1.2 South Africa
11.1.1.3 South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 South Africa: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.3.2 South Africa: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.3.3 South Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.3.4 South Africa: Upstream Bioprocessing Market Breakdown, by Mode
11.1.1.4 Saudi Arabia
11.1.1.5 Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.5.2 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.5.3 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.5.4 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Mode
11.1.1.6 UAE
11.1.1.7 UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.7.1 UAE: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.7.2 UAE: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.7.3 UAE: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.7.4 UAE: Upstream Bioprocessing Market Breakdown, by Mode
11.1.1.8 Rest of Middle East & Africa
11.1.1.9 Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.9.1 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.9.2 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.9.3 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.9.4 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Mode
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Upstream Bioprocessing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Esco Micro Pte Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Upstream Bioprocessing Market Segmentation
Table 2. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 3. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 4. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 5. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 6. Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 7. South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 8. South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 9. South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 10. South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 11. Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 12. Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 13. Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 14. Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 15. UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 16. UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 17. UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 18. UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 19. Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 20. Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 21. Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 22. Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 23. Recent Organic Growth Strategies in Upstream Bioprocessing Market
Table 24. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
Table 25. Glossary of Terms, Upstream Bioprocessing Market

LIST OF FIGURES

Figure 1. Upstream Bioprocessing Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Upstream Bioprocessing Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
Figure 6. Upstream Bioprocessing Market Share (%) – by Product Type (2022 and 2030)
Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Filters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Bags and Containers: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Upstream Bioprocessing Market Share (%) – by Workflow (2022 and 2030)
Figure 13. Media Preparation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Cell Separation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Upstream Bioprocessing Market Share (%) – by Usage Type (2022 and 2030)
Figure 17. Single-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Multi-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Upstream Bioprocessing Market Share (%) – by Mode (2022 and 2030)
Figure 20. In-house: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Outsourced: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa: Upstream Bioprocessing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. South Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Saudi Arabia: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. UAE: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Middle East & Africa: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Upstream Bioprocessing Market